MedPath

Effect of platelet rich fibrin (derived from blood) on orthodontic treatment duration

Phase 3
Not yet recruiting
Conditions
Disorder of teeth and supporting structures, unspecified, (2) ICD-10 Condition: K088||Other specified disorders of teethand supporting structures,
Registration Number
CTRI/2023/09/057788
Lead Sponsor
Dr Sonar Kapil Mahendra
Brief Summary

We are doing a randomized controlled trial to evaluate efficacy of injectable platelet rich fibrin in reducing orthodontic treatment duration in Class I moderate to severre crowding patients. The sample size of 20 is divided randomly into two groups, control and intervention. The subjects in intervention group are injected with I-PRF on two time intervals while subjects in control groups are not treated with the same.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. Age range 15 to 30 years irrespective of gender 2) Class I / half cusp Class II malocclusion cases with moderate to severe crowding in maxillary arch (>6mm calculated by Little’s Irregularity Index) 3) Overbite less than 50% 4) Full permanent dentition from second molar to second molar in both arches 5) Patients without significant medical history 6) Patients with healthy periodontium 7) Patients with positive informed consent.
Exclusion Criteria

EXCLUSION CRITERIA 1) Unfavourable/distally tipped canine position 2) Platelet count less than normal 150000 per mcL of blood.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Total treatment duration reduction percentage1.5 year
Secondary Outcome Measures
NameTimeMethod
Levelling and alignment improvement percentage1.5 year

Trial Locations

Locations (1)

All India Institute of Medical Sciences

🇮🇳

Delhi, DELHI, India

All India Institute of Medical Sciences
🇮🇳Delhi, DELHI, India
Dr Sonar Kapil Mahendra
Principal investigator
7219240637
kms210197@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.